2020
Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm
Smith LB, Desai NR, Dowd B, Everhart A, Herrin J, Higuera L, Jeffery MM, Jena AB, Ross JS, Shah ND, Karaca-Mandic P. Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm. International Journal Of Health Economics And Management 2020, 20: 299-317. PMID: 32350680, PMCID: PMC7725279, DOI: 10.1007/s10754-020-09282-2.Peer-Reviewed Original ResearchConceptsPermanent atrial fibrillationType 2 diabetesAtrial fibrillationPermanent atrial fibrillation patientsProvider-level factorsAtrial fibrillation patientsEffective new therapiesPrimary care providersUse of medicationsProvider-level characteristicsUtilization of treatmentHigh-quality health careDronedarone useInterrupted time-series regression modelsFibrillation patientsMedication useDiabetes patientsProvider characteristicsCare providersMedicare feeNew therapiesService claimsFemale providersPatientsMedications
2019
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.
Kent DM, van Klaveren D, Paulus JK, D'Agostino R, Goodman S, Hayward R, Ioannidis JPA, Patrick-Lake B, Morton S, Pencina M, Raman G, Ross JS, Selker HP, Varadhan R, Vickers A, Wong JB, Steyerberg EW. The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration. Annals Of Internal Medicine 2019, 172: w1-w25. PMID: 31711094, PMCID: PMC7750907, DOI: 10.7326/m18-3668.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThe Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement.
Kent DM, Paulus JK, van Klaveren D, D'Agostino R, Goodman S, Hayward R, Ioannidis JPA, Patrick-Lake B, Morton S, Pencina M, Raman G, Ross JS, Selker HP, Varadhan R, Vickers A, Wong JB, Steyerberg EW. The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement. Annals Of Internal Medicine 2019, 172: 35-45. PMID: 31711134, PMCID: PMC7531587, DOI: 10.7326/m18-3667.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsEvolution of the American College of Cardiology and American Heart Association Cardiology Clinical Practice Guidelines: A 10‐Year Assessment
DuBose‐Briski V, Yao X, Dunlay SM, Dhruva SS, Ross JS, Shah ND, Noseworthy PA. Evolution of the American College of Cardiology and American Heart Association Cardiology Clinical Practice Guidelines: A 10‐Year Assessment. Journal Of The American Heart Association 2019, 8: e012065. PMID: 31566106, PMCID: PMC6806052, DOI: 10.1161/jaha.119.012065.Peer-Reviewed Original ResearchConceptsValvular heart diseaseClinical practice guidelinesAmerican Heart AssociationLevel of evidenceAmerican CollegeLOE BHeart failureHeart AssociationHeart diseasePractice guidelinesCardiology/American Heart Association (ACC/AHA) guideline recommendationsCardiology/American Heart Association guidelinesCardiology/American Heart AssociationMedian proportionCardiology clinical practice guidelinesAmerican Heart Association guidelinesHeart Association guidelinesClass of recommendationLOE AGuideline recommendationsResults ThirtyAssociation guidelinesMedian numberStable ischemiaLevel I
2014
Restricting Interactions With Industry to Promote Evidence-Based Prescribing
Ross JS. Restricting Interactions With Industry to Promote Evidence-Based Prescribing. JAMA Internal Medicine 2014, 174: 1290-1290. PMID: 24912054, DOI: 10.1001/jamainternmed.2014.1862.Commentaries, Editorials and LettersDescriptions and Interpretations of the ACCORD-Lipid Trial in the News and Biomedical Literature: A Cross-Sectional Analysis
Downing NS, Cheng T, Krumholz HM, Shah ND, Ross JS. Descriptions and Interpretations of the ACCORD-Lipid Trial in the News and Biomedical Literature: A Cross-Sectional Analysis. JAMA Internal Medicine 2014, 174: 1176-1182. PMID: 24796406, PMCID: PMC4124903, DOI: 10.1001/jamainternmed.2014.1371.Peer-Reviewed Original ResearchConceptsACCORD lipid trialACCORD-LipidFibrate useTrial interpretationImproved cardiovascular outcomesCross-sectional studyCross-sectional analysisStatin therapyCardiovascular outcomesCardiovascular riskDiabetes (ACCORD) trialDiabetes mellitusConflicts of interestTrialsPatientsFenofibrateAuthor conflictsLipid componentsMellitusTherapyPhysiciansMonthsPhysician clinical management strategies and reasoning: a cross-sectional survey using clinical vignettes of eight common medical admissions
Smith KL, Ashburn S, Aminawung JA, Mann M, Ross JS. Physician clinical management strategies and reasoning: a cross-sectional survey using clinical vignettes of eight common medical admissions. BMC Health Services Research 2014, 14: 176. PMID: 24742131, PMCID: PMC4021187, DOI: 10.1186/1472-6963-14-176.Peer-Reviewed Original ResearchConceptsClinical management strategiesMedical admissionsGuideline supportCross-sectional surveyClinical vignettesEvidence-based careAvoidance of careYears of ageLocal practice patternsInternal medicine programsSupportive evidenceResultsOur samplePractice patternsPhysicians' likelihoodClinical scenariosAdmissionBrief clinical scenariosDiagnostic testsPhysiciansClinical responsibilitiesMedicine programsStrong evidenceManagement strategiesEvidence disseminationCareMoving Forward From rhBMP-2
Low JB, Ross JS, Krumholz HM. Moving Forward From rhBMP-2. Spine 2014, 39: 531-532. PMID: 24503690, PMCID: PMC3981828, DOI: 10.1097/brs.0000000000000256.Commentaries, Editorials and LettersBone Morphogenetic Protein 2Clinical Trials as TopicEvidence-Based MedicineHumansRecombinant Proteins
2013
When Choosing Statin Therapy: The Case for Generics
Green JB, Ross JS, Jackevicius CA, Shah ND, Krumholz HM. When Choosing Statin Therapy: The Case for Generics. JAMA Internal Medicine 2013, 173: 229-232. PMID: 23303273, DOI: 10.1001/jamainternmed.2013.1529.Commentaries, Editorials and LettersMeSH KeywordsCardiovascular DiseasesChoice BehaviorDrugs, GenericDyslipidemiasEvidence-Based MedicineHumansHydroxymethylglutaryl-CoA Reductase InhibitorsTherapeutic EquivalencyTamiflu: 14 flu seasons and still questions
Krumholz HM, Jackevicius CA, Ross JS. Tamiflu: 14 flu seasons and still questions. The BMJ 2013, 346: f547. PMID: 23355545, DOI: 10.1136/bmj.f547.Commentaries, Editorials and LettersMeSH KeywordsAntiviral AgentsDisease OutbreaksEvidence-Based MedicineHumansInfluenza, HumanOseltamivirTreatment Outcome
2011
A Model for Dissemination and Independent Analysis of Industry Data
Krumholz HM, Ross JS. A Model for Dissemination and Independent Analysis of Industry Data. JAMA 2011, 306: 1593-1594. PMID: 21990302, PMCID: PMC3688082, DOI: 10.1001/jama.2011.1459.Commentaries, Editorials and LettersSwitching From Rosiglitazone: Thinking Outside the Class
Lipska KJ, Ross JS. Switching From Rosiglitazone: Thinking Outside the Class. JAMA 2011, 305: 820-821. PMID: 21304068, DOI: 10.1001/jama.2011.193.Commentaries, Editorials and Letters
2008
Statistical Models and Patient Predictors of Readmission for Heart Failure: A Systematic Review
Ross JS, Mulvey GK, Stauffer B, Patlolla V, Bernheim SM, Keenan PS, Krumholz HM. Statistical Models and Patient Predictors of Readmission for Heart Failure: A Systematic Review. JAMA Internal Medicine 2008, 168: 1371-1386. PMID: 18625917, DOI: 10.1001/archinte.168.13.1371.Peer-Reviewed Original ResearchMeSH KeywordsDisease ProgressionEvidence-Based MedicineFemaleHeart FailureHospitalizationHumansIncidenceMaleModels, StatisticalPatient ReadmissionPredictive Value of TestsProportional Hazards ModelsQuality-Adjusted Life YearsRisk FactorsSensitivity and SpecificitySeverity of Illness IndexSurvival AnalysisUnited StatesConceptsPatient characteristicsPatient readmission riskReadmission riskPatient riskSystematic reviewReadmission ratesHospital ratesOvid Evidence-Based Medicine ReviewsEligible English-language publicationsEvidence-Based Medicine ReviewsHeart failure hospitalizationPatient risk stratificationEnglish-language literatureEnglish-language publicationsFailure hospitalizationHF hospitalizationAdult patientsHeart failureHospital readmissionMedicine ReviewsRisk stratificationPatient predictorsInclusion criteriaReadmissionCombined outcome